Solvay set for 1.5 billion euro impairment as sales sink

BRUSSELS (Reuters) - Belgian chemicals group Solvay is likely to take an impairment charge of 1.5 billion euros (£1.3 billion) as sales were set to fall by around 20% in the second quarter due to the impact of the COVID-19 pandemic, it said on Wednesday. The company said challenges had increased in the April-June period from the first three months of 2020, with sales down 20% across April and May and a similar demand trend seen for June.Solvay, whose products range from base chemicals such as..